GRI Bio, Inc. (GRI)
NASDAQ: GRI · IEX Real-Time Price · USD
1.670
-0.080 (-4.57%)
At close: Jul 19, 2024, 4:00 PM
1.710
+0.040 (2.40%)
Pre-market: Jul 22, 2024, 7:22 AM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $1.01 million as of July 22, 2024. Its market cap has decreased by -92.06% in one year.
Market Cap
1.01M
Enterprise Value
-2.93M
1-Year Change
-92.06%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since February 10, 2021, GRI Bio's market cap has decreased from $46.40M to $1.01M, a decrease of -97.83%. That is a compound annual growth rate of -67.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 500.00K | -58.33% |
| Dec 29, 2023 | 1.20M | -67.57% |
| Dec 30, 2022 | 3.70M | -90.91% |
| Dec 31, 2021 | 40.70M | -12.28% |
| Feb 10, 2021 | 46.40M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seelos Therapeutics | 1.50M |
| Salarius Pharmaceuticals | 1.45M |
| Dermata Therapeutics | 1.26M |
| LogicMark | 1.25M |
| Bone Biologics | 1.22M |
| China SXT Pharmaceuticals | 799.91K |
| Bluejay Diagnostics | 319.15K |
| Biodexa Pharmaceuticals | 222.44K |